News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dudley Robert Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
SC 13D/A
| Dudley Robert Michael reports a 1.9% stake in TransCode Therapeutics, Inc. |
| 10/02/2023 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Bought 98,000 shares
@ $0.51, valued at
$50k
|
|
| 06/16/2023 |
SC 13D/A
| Dudley Robert Michael reports a 6% stake in TransCode Therapeutics, Inc. |
| 05/19/2023 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 735,000 options to buy
@ $0.2834, valued at
$208.3k
|
|
| 12/19/2022 |
SC 13D
| Dudley Robert Michael reports a 12.7% stake in TransCode Therapeutics, Inc. |
| 12/19/2022 |
SC 13G
| Dudley Robert Michael reports a 10.6% stake in TransCode Therapeutics, Inc. |
| 12/14/2022 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $0.51, valued at
$68.9k
|
|
| 09/16/2022 |
4
| Dudley Robert Michael (CEO) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.15, valued at
$23k
|
|
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|